Gerresheimer AG/€GXI
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Gerresheimer AG
Gerresheimer AG is a prominent player in the healthcare and life sciences industry, specializing in the production of glass and plastic products for pharmaceutical and cosmetic packaging. The company’s key offerings include pharmaceutical vials, prefillable syringes, glass and plastic packaging for drugs, as well as delivery systems for the safe administration of medications. Founded in 1864, Gerresheimer has evolved into a global entity with headquarters in Düsseldorf, Germany, and operates manufacturing sites in Europe, the Americas, and Asia. Its strategic strength lies in a broad product portfolio and advanced technical expertise, enabling it to cater to the stringent requirements of its diverse clientele in the healthcare sector. The company’s comprehensive geographic footprint and commitment to innovation bolster its competitive position in the market.
Ticker
€GXI
Sector
Primary listing
XETRA
Employees
13,535
Headquarters
Website
Gerresheimer AG Metrics
BasicAdvanced
€875m
37.84
€0.68
0.73
-
Price and volume
Market cap
€875m
Beta
0.73
52-week high
€51.90
52-week low
€14.90
Average daily volume
51k
Financial strength
Current ratio
0.983
Quick ratio
0.406
Long term debt to equity
119.461
Total debt to equity
161.827
Dividend payout ratio (TTM)
0.43%
Interest coverage (TTM)
1.44%
Profitability
EBITDA (TTM)
384.986
Gross margin (TTM)
26.89%
Net profit margin (TTM)
1.04%
Operating margin (TTM)
6.86%
Effective tax rate (TTM)
27.40%
Revenue per employee (TTM)
€170,000
Management effectiveness
Return on assets (TTM)
2.34%
Return on equity (TTM)
1.81%
Valuation
Price to earnings (TTM)
37.839
Price to revenue (TTM)
0.393
Price to book
0.62
Price to tangible book (TTM)
-2.83
Price to free cash flow (TTM)
-2.013
Free cash flow yield (TTM)
-49.68%
Free cash flow per share (TTM)
-12.709
Growth
Revenue change (TTM)
11.83%
Earnings per share change (TTM)
-79.57%
3-year revenue growth (CAGR)
9.28%
10-year revenue growth (CAGR)
5.36%
3-year earnings per share growth (CAGR)
-38.33%
10-year earnings per share growth (CAGR)
-11.17%
3-year dividend per share growth (CAGR)
-68.25%
10-year dividend per share growth (CAGR)
-25.41%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs